Journal of Orthopedic and Spine Trauma

Published by: Kowsar

Application of Transexamic Acid in Total Hip Arthroplasty: Review of Current Concepts

Adel Ebrahimpour 1 , Mehrdad Sadighi 2 , * , Mohsen Karami 1 , Mohammad Reza Minator Sajadi 2 , Reza Zandi 2 and Amin Karimi 2
Authors Information
1 Associated Professor of Orthopedic Surgery, Taleghani Hospital, Shahid Beheshti Medical University of Sciences, Tehran, Iran
2 Assistant Professor of Orthopedic Surgery, Taleghani Hospital, Shahid Beheshti Medical University of Sciences, Tehran, Iran
Article information
  • Journal of Orthopedic and Spine Trauma: December 2016, 2 (4); e10893
  • Published Online: December 31, 2016
  • Article Type: Review Article
  • Received: October 8, 2016
  • Revised: November 12, 2016
  • Accepted: December 10, 2016
  • DOI: 10.5812/jost.10893

To Cite: Ebrahimpour A, Sadighi M, Karami M, Minator Sajadi M R, Zandi R, et al. Application of Transexamic Acid in Total Hip Arthroplasty: Review of Current Concepts, J Orthop Spine Trauma. 2016 ; 2(4):e10893. doi: 10.5812/jost.10893.

Copyright © 2016, Journal of Orthopedic and Spine Trauma. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Introduction
3. Efficacy of TXA in Total Hip Arthroplasty
4. Topical Versus Intravenous Administration of TXA
5. TXA and Thrombotic Events
6. Cost-Effectiveness of Tranexamic Acid
7. Current Concept
  • 1. Blumberg N, Kirkley SA, Heal JM. A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery. American J Surgery. 1996; 171(3): 324-30[DOI]
  • 2. Toy PT, Kaplan EB, McVay PA, Lee SJ, Strauss RG, Stehling LC. Blood loss and replacement in total hip arthroplasty: a multicenter study. The Preoperative Autologous Blood Donation Study Group. Transfusion. 1992; 32(1): 63-7[PubMed]
  • 3. Okamoto S, Sato S, Takada Y, Okamoto U. An Active Stereo-Isomer (Trans-Form) of Amcha and Its Antifibrinolytic (Antiplasminic) Action in Vitro and in Vivo. Keio J Med. 1964; 13: 177-85[PubMed]
  • 4. Melander B, Gliniecki G, Granstrand B, Hanshoff G. Biochemistry and toxicology of amikapron; the antifibrinolytically active isomer of amcha. (a comparative study with-aminocaproic acid). Acta Pharmacologica et Toxicologica. 2009; 22(4): 340-52[DOI]
  • 5. Petaja J, Myllynen P, Myllyla G, Vahtera E. Fibrinolysis after application of a pneumatic tourniquet. Acta Chir Scand. 1987; 153(11-12): 647-51[PubMed]
  • 6. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999; 57(6): 1005-32[PubMed]
  • 7. Samama CM. A direct antifibrinolytic agent in major orthopedic surgery. Orthopedics. 2004; 27(6 Suppl): 675-80[PubMed]
  • 8. Hardy JF, Desroches J. Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anaesth. 1992; 39(4): 353-65[DOI][PubMed]
  • 9. Andersson L, Nilsson IM, Nilehn JE, Hedner U, Granstrand B, Melander B. Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid. Scand J Haematol. 1965; 2(3): 230-47[PubMed]
  • 10. Eriksson O, Kjellman H, Pilbrant A, Schannong M. Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers. Eur J Clin Pharmacol. 1974; 7(5): 375-80[PubMed]
  • 11. Ahlberg A, Eriksson O, Kjellman H. Diffusion of tranexamic acid to the joint. Acta Orthop Scand. 1976; 47(5): 486-8[PubMed]
  • 12. LYSTEDA (tranexamic acid) tablets. . Highlights of prescribing information.
  • 13. Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ. 2014; 349[DOI][PubMed]
  • 14. Ho KM, Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care. 2003; 31(5): 529-37[PubMed]
  • 15. Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res. 2009; 123(5): 687-96[DOI][PubMed]
  • 16. Stoicea N, Bergese SD, Ackermann W, Moran KR, Hamilton C, Joseph N. Current status of blood transfusion and antifibrinolytic therapy in orthopedic surgeries. Frontiers Surgery. 2015; 2
  • 17. Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br. 2011; 93(1): 39-46[DOI][PubMed]
  • 18. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, McClelland B, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2007; (4)[DOI][PubMed]
  • 19. Wei Z, Liu M. The effectiveness and safety of tranexamic acid in total hip or knee arthroplasty: a meta-analysis of 2720 cases. Transfus Med. 2015; 25(3): 151-62[DOI][PubMed]
  • 20. Xu X, Xiong S, Wang Z, Li X, Liu W. Topical administration of tranexamic acid in total hip arthroplasty: A meta-analysis of Randomized Controlled Trials. Drug Discov Ther. 2015; 9(3): 173-7[DOI][PubMed]
  • 21. Wang C, Xu GJ, Han Z, Ma JX, Ma XL, Jiang X, et al. Topical application of tranexamic acid in primary total hip arthroplasty: a systemic review and meta-analysis. Int J Surg. 2015; 15: 134-9[DOI][PubMed]
  • 22. North WT, Mehran N, Davis JJ, Silverton CD, Weir RM, Laker MW. Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial. J Arthroplasty. 2016; 31(5): 1022-6[DOI][PubMed]
  • 23. Gao F, Sun W, Guo W, Li Z, Wang W, Cheng L. Topical Application of Tranexamic Acid Plus Diluted Epinephrine Reduces Postoperative Hidden Blood Loss in Total Hip Arthroplasty. J Arthroplasty. 2015; 30(12): 2196-200[DOI][PubMed]
  • 24. Xie J, Ma J, Yue C, Kang P, Pei F. Combined use of intravenous and topical tranexamic acid following cementless total hip arthroplasty: a randomised clinical trial. Hip Int. 2016; 26(1): 36-42[DOI][PubMed]
  • 25. Nishihara S, Hamada M. Does tranexamic acid alter the risk of thromboembolism after total hip arthroplasty in the absence of routine chemical thromboprophylaxis? Bone Joint J. 2015; 97-B(4): 458-62[DOI][PubMed]
  • 26. Harris RN, Moskal JT, Capps SG. Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study. J Arthroplasty. 2015; 30(2): 192-5[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments